Skip to main content
. 2013 Mar 19;16(2):131–139. doi: 10.1111/hpb.12086

Table 3.

Summary of reasons for off-treatment and off-study shifts

Reasons for stopping treatment Patients, n (%)
 Treatment completed 7 (30.4%)
 Progressive disease or relapse 3 (13.0%)
 AE, side-effects, complications 7 (30.4%)
 Death on study 1 (4.3%)
 Patient withdrawal 1 (4.3%)
 Alternative treatment 3 (13.0%)
 Other disease 1 (4.3%)
Reasons for withdrawing from study   (n = 16)
 Patient withdrawn 15 (93.7%)
 Death 1 (6.3%)

AE, adverse events.